Vacccinations Flashcards

1
Q

Vaccine

A

Something that stimulates the immune system without causing serious harm or side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Features of an ideal vaccine

A
  • Cheap
  • Completely safe
  • Easy to administer so can be given to many people quickly
  • Single dose, needle-free → not always doable but is ideal to make it quicker and so higher chance more people will take them i.e. no fear of needles
  • Stable so can move between site of manufacture and site of administration properly
  • Active against all variants e.g. with influenza the virus changes every year so new vaccine needed
  • Life-long protection so you get immunised at birth and are protected for life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do vaccines stop infection

A

Prevent entry of pathogen into cell:

1) bind to virus and neutralise it to stop it from ever infecting cells in the first place

2) Opsonisation of the virus that leads to macrophages engulfing it → driven by constant region on antibody
Booster immune response:
Antigens in vaccine activate CD4 T cells

Enables killing of infected cells:
CD4 triggers CD8 T cells and activate B cells to make Ig

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

R0

A

Is the reproduction number
The number of cases one case generates in average
R0<1 infection dies in long run
R0>1infectiin can spread and expand in population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rt value

A

Alteration of R0 value due to vaccination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is in vaccines

A

Antigens
Adjuvants
Stabilizing stuff eg buffers
Residual traces eg formaldehyde
Water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What form can the antigens be In

A
  • Inactivated protein e.g. tetanus toxoid
  • Recombinant protein e.g. Hep B
  • Live attenuated pathogen e.g. polio/BCG
  • Dead pathogen e.g. split flu vaccine
  • Carbohydrate e.g. S. pneumoniae
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Adjuvants

A

a substance which enhances the body’s immune response to an antigen.
Alum is usually used in vaccines-it stores the antigen at the site of injection and enables DC to see more of it
Induce danger signals that activate dendritic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mechanism of adjuvant

A

Stimulates DC

DC uptakes antigen and moves to lymph node

Upregulates stimulatory signalling and cytokines

!https://s3-us-west-2.amazonaws.com/secure.notion-static.com/e67e593b-5f11-40d8-800c-1b8db4785992/Untitled.png

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Inactivated toxoid vaccine

A
  • e.g. tetanus toxoid → vaccine has chemically inactivated form of toxin
  • The vaccine induces antibody which blocks the toxin from binding to cells (nerves in tetanus’ case)
  • Advantages: cheap, well characterised safe, in use for many decades
  • Disadvantages: requires good understanding of biology of infection & not all organisms encode toxins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Recombinant protein vaccine

A
  • e.g. hep B surface antigen
  • The gene from 1 organism is isolated and moved into a different organism. Protein is mass produced e.g. with hep B it is its surface antigen, which is then injected into body
  • This vaccine induces classic neutralising antibodies that combine the protein and stop the virus getting into cells
  • Advantages: Pure, safe
  • Disadvantages: relatively expensive, not very immunogenic (work much better with adjuvant though), has not proved to be answer to all pathogens

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is this issue with inactivated toxoid vaccines and recombinant protein vaccines

A

Works well for protein antigens but bacteria have a polysaccharide capsule surrounding them which doesn’t induce a B cell response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Conjugate/carbohydrate vaccines

A
  • e.g. S. pneumoniae
  • The vaccine is a polysaccharide coat component that’s coupled to an immunogenic ‘carrier’ protein i.e. a sugar molecule stuck to a protein molecule
  • A DC engulfs the whole antigen and presents the protein part onto MHCII. A B cell takes up the polysaccharide part of the antigen and presents it onto its MHCII
  • Tfh is primed by DC through interacting with the DC’s MHCII presented peptide and then goes to the matching B cell (presenting the same thing) and boosts it
  • B cells produces a lot of anti-sugar antibodies
  • Advantages: Improves immunogenicity, highly effective at controlling bacterial infection
  • Disadvantages: cost, carrier protein interference, very strain specific, polysaccharide alone is poorly immunogenic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dead pathogen vaccines

A
  • e.g. influenza split vaccine
  • Rather than using a single antigen, it’s a chemically killed pathogen
  • This induces antibody and T cell responses
  • Advantages: Leaves antigenic components intact and in context of other antigen. Immunogenic because of the inclusion of other component. Cheap and quick
  • Disadvantages: Fixing/killing can alter chemical structure of antigen, quite ‘dirty’, requires the capacity to grow the pathogen e.g. H5N1, vaccine induced pathogenicity a risk, risk of contamination with live pathogen (polio), not happened since 1953
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Live attenuated vaccines

A

e.g. BCG, Live Attenuated Flu Vaccine (LAIV), Polio vaccine
Serial passage attenuated pathogens as it leads to loss of virulence factors

  • Because they replicate in situ infections they trigger the innate response and boost the immune response
  • Advantages: Induce a strong immune response. Can induce a local immune response in the site where infection might occur (e.g. LAIV)
  • Disadvantages: Can revert to virulence, can infect immunocompromised (BCG/HIV), attenuation may lose key antigens, can be competed out by other infections e.g. if you give polio vaccine to someone with a gut infection you’re less likely to get a good immune response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why do we need new vaccines

A

Changing demographics
Changing environment
New disease
Old disease
Antibiotic resistance

17
Q

Development issues

A
  • Time taken to develop a new vaccine has gone from 8 years in 60s to 15 years now
  • Cost of vaccine development is high
  • Cost of the product